Nuveen LLC Invests $787,000 in Viemed Healthcare, Inc. $VMD

Nuveen LLC acquired a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 108,112 shares of the company's stock, valued at approximately $787,000. Nuveen LLC owned 0.27% of Viemed Healthcare at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Divisadero Street Capital Management LP raised its position in shares of Viemed Healthcare by 84.8% during the 4th quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock worth $5,183,000 after purchasing an additional 296,481 shares during the last quarter. Expect Equity LLC purchased a new position in shares of Viemed Healthcare during the 4th quarter worth approximately $1,369,000. GSA Capital Partners LLP increased its holdings in Viemed Healthcare by 497.7% in the 1st quarter. GSA Capital Partners LLP now owns 149,791 shares of the company's stock valued at $1,090,000 after purchasing an additional 124,731 shares during the last quarter. Segall Bryant & Hamill LLC boosted its position in Viemed Healthcare by 252.1% in the 1st quarter. Segall Bryant & Hamill LLC now owns 130,229 shares of the company's stock valued at $948,000 after buying an additional 93,242 shares during the period. Finally, Millennium Management LLC purchased a new position in Viemed Healthcare in the 4th quarter valued at approximately $573,000. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Viemed Healthcare news, VP Jerome Cambre sold 4,880 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total transaction of $35,721.60. Following the transaction, the vice president owned 84,191 shares of the company's stock, valued at $616,278.12. This trade represents a 5.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nitin Kaushal sold 34,100 shares of the stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00. Following the transaction, the director directly owned 126,843 shares in the company, valued at approximately $889,169.43. This represents a 21.19% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 97,922 shares of company stock worth $703,886. 20.00% of the stock is owned by company insiders.

Viemed Healthcare Stock Up 0.9%

NASDAQ:VMD traded up $0.06 during midday trading on Friday, hitting $6.88. 181,068 shares of the company were exchanged, compared to its average volume of 179,679. The company has a fifty day simple moving average of $6.80 and a 200 day simple moving average of $6.95. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $9.81. The company has a current ratio of 1.48, a quick ratio of 1.37 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $266.88 million, a PE ratio of 20.24 and a beta of 1.38.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.08 EPS for the quarter, meeting analysts' consensus estimates of $0.08. Viemed Healthcare had a net margin of 5.80% and a return on equity of 10.38%. The business had revenue of $63.06 million during the quarter, compared to analysts' expectations of $63.50 million.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.